With staggering growth in the number of people addicted to and dying from opioids, government, the medical community and recovery programs are working to turn the tide.
This pervasive little-understood illness is finally getting the notice it deserves, with current attention focusing on better understanding and prevention.
The U.S. market for IVIG continues to grow well over 5 percent annually. What is driving the market demand?
Gene therapy is the one remaining therapeutic option for treating severe combined immunodeficiency by correcting it at its most fundamental genetic level.
As the number of cancer cases continues to rise, scientists are bringing to light exciting discoveries that are being used to create targeted therapies to treat and, it is hoped, to eventually cure cancer.
